Dr. Michael Snyder

It was true for the Tony Robbins one.

And the Byron Katie one, we now have some of the omics data back in there.

They do seem to improve in their inflammatory markers as well.

So we have some data there.

That's not yet published.

I've never done it myself.

So anyway, we did see a positive result on the pilot study, and that was 20 – I don't know, 27 people.

I may have the number wrong, but it's a small number.

And then we now have done a follow-up and –

Well, I should say actually for the first one, that actually went out even further now.

They have some additional data points.

But in the follow-up, there we did a much bigger one at 600, almost 700 people who went through Tony Robbins.

And then we had another set of people

who didn't do Tony Robbins, who we also profiled.

And same thing, they wore smartwatches.

We had to scramble to get the IRB approval.

It's always a rate-limiting step.

So we didn't get as many wearables on folks ahead of time, but we did do the micro-sampling.

We did do all the surveys, and we have a battery of wellness surveys.

It wouldn't be official depression scores and things, but they're things about, you know, are you depressed and anxiety and burnout and all kinds of stuff.